Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities

European Journal of Immunology

Volumn 28, Issue 12, 1998, Pages 4029-4036

  Stoltze, Lars ^a   Dick, Tobias P ^a,c   Deeg, Martin ^b   Pömmerl, Beate ^a   Rammensee, Hans Georg ^a   Schild, Hansjörg ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen processing; Cytotoxic T lymphocyte; Lactacystin; Proteasome

Indexed keywords

ENZYME INHIBITOR; NUCLEOPROTEIN; PROTEASOME; PROTEINASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; VESICULAR STOMATITIS VIRUS;

EID: 0031771008     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N     Document Type: Article

References (33)

1. Falk, K., Rötzschke, O., Stavanovic, S., Jung, G. and Rammensee, H.-G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 351: 290-296.
2. Cerundolo, V., Benham, A., Braud, V., Mukherjee, S., Gould, K., Macino, B., Neefjes, J. and Townsend, A., The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 1997. 27: 336-341.
3. York, I. A. and Rock, K. L., Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 1996. 14: 369-396.
4. Kuckelkorn, U., Frentzel, S., Kraft, R., Kostka, S., Groettrup, M. and Kloetzel, P.-M., Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-g. Eur. J. Immunol. 1995. 25: 2605-2611.
5. Gaczynska, M., Goldberg, A. L., Tanaka, K., Hendil, K. B. and Rock, K. L., Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-gamma-induced subunits LMP2 and LMP7. J. Biol. Chem. 1996. 271: 17275-17280.
6. d in proteasome subnit LMP2- and LMP7-deficient cells. Eur. J. Immunol. 1994. 24: 1863-1868.
7. Van Kaer, L., Ashton Rickardt, P. G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K. L., Goldberg, A. L., Doherty, P. C. and Tonegawa, S., Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994. 1: 533-541.
8. Fehling, H. J., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U. and von Boehmer, M., MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994. 265: 1234-1237.
9. Stohwasser, R., Kuckelkorn, U., Kraft, R., Kostka, S. and Kloetzel, P. M., 20S proteasome from LMP7 knock out mice reveals altered proteolytic activities and cleavage site preferences. FEBS Lett. 1996. 383: 109-113.
10. Yang, Y., Fruh, K., Ahn, K. and Peterson, P. A., In vivo assembly of the proteasomal complexes, implications for antigen processing. J. Biol. Chem. 1995. 270: 27687-27694.
11. Dick, T. P., Ruppert, T., Groettrup, M., Kloetzel, P. M., Kuehn, L., Koszinowski, U. H., Stevanovic, S., Schild, H. and Rammensee, H.-G., Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 1996. 86: 253-262.
12. Michalek, M. T., Grant, E. P., Gramm, C., Goldberg, A. L. and Rock, K. L., A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993. 363: 552-554.
13. Cox, J. H., Galardy, P., Bennink, J. R. and Yewdell, J. W., Presentation of endogeneous and exogenous antigens is not affected by inactivation of E1 ubiquitinactivating enzyme in temperature-sensitive cell lines. J. Immunol. 1995. 154: 511-519.
14. Falk, K., Rötzschke, O. and Rammensee, H.-G., Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990. 348: 248-251.
15. Anderson, K., Cresswell, P., Gammon, M., Hermes, J., Williamson, A. and Zweerink, H., Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 1991. 174: 489-492.
16. Snyder, H. L., Yewdell, J. W. and Bennink, J. R., Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 1994. 180: 2389-2394.
17. Craiu, A., Akopian, T., Goldberg, A. and Rock, K. L., Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA 1997. 94: 10850-10855.
18. Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L. and Rock, K. L., Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 1997. 272: 13437-13445.
19. Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J. and Schreiber, S. L., Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995. 268: 726-731.
20. Bogyo, M., McMaster, J. S., Gaczynska, M., Tortorella, D., Goldberg, A. L. and Ploegh, H., Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HsIV by a new class of inhibitors. Proc. Natl. Acad. Sci. USA 1997. 94: 6629-6634.
21. Niedermann, G., Butz, S., Ihlenfeldt, H. G., Grimm, R., Lucciari, M., Hoschützky, H., Jung, G., Maier, B. and Eichmann, K., Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 1995. 2: 289-299.
22. Eisenlohr, L. C., Yewdell, J. W. and Bennink, J. R., Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 1992. 175: 481-487.
23. Elliott, T., Willis, A., Cerundolo, V. and Townsend, A., Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 1995. 181: 1481-1491.
24. Harris, C. A., Hunte, B., Krauss, M. R., Taylor, A. and Epstein, L. B., Induction of leucine aminopeptidase by interferon-gamma. Identification by protein microsequencing after purification by preparative two-dimensional gel electrophoresis. J. Biol. Chem. 1992. 267: 6865-6869.
25. Momburg, F., Roelse, J., Howard, J. C., Butcher, G. W., Hämmerling, G. J. and Neefjes, J. J., Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994. 367: 648-651.
26. Moore, M. W., Carbone, F. R. and Bevan, M. J., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988. 54: 777-785.
27. Lin, A. Y., Devaux, B., Green, A., Sagerstrom, C., Elliott, J. F. and Davis, M. M., Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 1990. 249: 677-679.
28. Rötzscnke, O., Falk, K., Stavanovic, S., Jung, G., Walden, P. and Rammensee, H.-G., Exact prediction of a natural T cell epitope. Eur. J. Immunol. 1991. 21: 2891-2894.
29. b molecule. Nature 1990. 348: 213-216.
30. Gavin, M. A., Gilbert, M. J., Riddell, S. R., Greenberg, P. D. and Bevan, M. J., Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 1993. 151: 3971-3980.
31. Rammensse, H.-G., Schild, H. and Theopold, U., Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase. Immunogenetics 1989. 30: 296-302.
32. Storkus, W. J., Zeh, H. J. 3d, Salter, R. D. and Lotze, M. T., Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 1993. 14: 94-103.
33. Schild, H., Norda, M., Deres, K., Falk, K., Rötzschke, O., Wiesmüller, K. H., Jung, G. and Rammensee, H.-G., Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. J. Exp. Med. 1991. 174: 1665-1668.